Concentrix Corporation | Mid-cap | Technology

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Feb 2025

Income Metrics

Revenue 2.4B
Gross Profit 855.9M 36.08%
Operating Income 168.9M 7.12%
Net Income 70.3M 2.96%
EPS (Diluted) $1.04

Balance Sheet Metrics

Total Assets 11.9B
Total Liabilities 7.9B
Shareholders Equity 4.0B
Debt to Equity 1.95

Cash Flow Metrics

Operating Cash Flow 231.1M
Free Cash Flow 180.7M

Revenue & Profitability Trend

Concentrix Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i9.6B7.1B6.3B5.6B4.7B
Cost of Goods Sold i6.2B4.5B4.1B3.6B3.1B
Gross Profit i3.4B2.6B2.3B2.0B1.7B
Gross Margin % i35.9%36.2%35.7%35.3%35.2%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i2.9B1.9B1.6B1.4B1.4B
Other Operating Expenses i-----
Total Operating Expenses i2.9B1.9B1.6B1.4B1.4B
Operating Income i596.4M661.3M640.2M572.4M308.8M
Operating Margin % i6.2%9.3%10.1%10.2%6.5%
Non-Operating Items
Interest Income i-----
Interest Expense i321.8M201.0M70.1M23.0M48.3M
Other Non-Operating Income24.7M-52.1M34.9M6.3M7.4M
Pre-tax Income i299.3M408.2M605.0M555.7M267.9M
Income Tax i48.1M94.4M169.4M150.1M103.1M
Effective Tax Rate % i16.1%23.1%28.0%27.0%38.5%
Net Income i251.2M313.8M435.6M405.6M164.8M
Net Margin % i2.6%4.4%6.9%7.3%3.5%
Key Metrics
EBITDA i1.3B997.5M984.6M855.9M592.8M
EPS (Basic) i$3.72$5.72$8.34$7.78$3.19
EPS (Diluted) i$3.71$5.70$8.28$7.70$3.19
Basic Shares Outstanding i6497700053801000513530005135500051602000
Diluted Shares Outstanding i6497700053801000513530005135500051602000

Income Statement Trend

Concentrix Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i240.6M295.3M145.4M182.0M152.7M
Short-term Investments i-----
Accounts Receivable i1.1B1.1B782.0M714.0M644.8M
Inventory i-----
Other Current Assets486.1M453.3M206.4M152.1M185.5M
Total Current Assets i2.8B2.9B1.8B1.5B1.4B
Non-Current Assets
Property, Plant & Equipment i00000
Goodwill i12.3B13.0B6.8B4.3B4.5B
Intangible Assets i2.3B2.8B985.6M655.5M799.0M
Long-term Investments-----
Other Non-Current Assets1.2B1.0B621.6M627.1M667.5M
Total Non-Current Assets i9.1B9.6B4.9B3.5B3.8B
Total Assets i12.0B12.5B6.7B5.0B5.2B
Liabilities
Current Liabilities
Accounts Payable i209.8M243.6M161.2M129.4M140.6M
Short-term Debt i2.5M2.3M--33.8M
Current Portion of Long-term Debt-----
Other Current Liabilities-----
Total Current Liabilities i2.0B2.1B1.1B968.2M1.0B
Non-Current Liabilities
Long-term Debt i4.7B4.9B2.2B802.0M1.1B
Deferred Tax Liabilities i312.6M414.2M105.5M109.5M153.6M
Other Non-Current Liabilities910.3M920.5M512.0M546.4M601.9M
Total Non-Current Liabilities i6.0B6.3B2.8B1.5B1.9B
Total Liabilities i8.0B8.3B4.0B2.4B2.9B
Equity
Common Stock i7.0K7.0K5.0K5.0K0
Retained Earnings i1.2B1.0B774.1M392.5M0
Treasury Stock i421.4M272.0M190.8M57.5M0
Other Equity-----
Total Shareholders Equity i4.0B4.1B2.7B2.6B2.3B
Key Metrics
Total Debt i4.7B4.9B2.2B802.0M1.1B
Working Capital i846.6M784.6M622.2M574.9M414.7M

Balance Sheet Composition

Concentrix Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i251.2M313.8M435.6M405.6M164.8M
Depreciation & Amortization i705.8M388.3M309.5M277.2M276.6M
Stock-Based Compensation i96.1M62.1M47.1M36.2M15.6M
Working Capital Changes i-166.9M-10.7M-163.4M-143.1M33.3M
Operating Cash Flow i648.8M654.0M600.4M551.8M489.6M
Investing Activities
Capital Expenditures i-238.8M-180.5M-140.0M-149.1M-171.3M
Acquisitions i-5.5M-1.9B-1.7B70.4M-5.6M
Investment Purchases i----0
Investment Sales i----0
Investing Cash Flow i-244.3M-2.1B-1.8B-78.6M-109.2M
Financing Activities
Share Repurchases i-149.5M-81.2M-133.3M-57.5M0
Dividends Paid i-83.8M-63.5M-53.4M-13.1M0
Debt Issuance i2.2B4.4B3.9B1.3B1.2B
Debt Repayment i-2.4B-2.4B-2.5B-1.7B-1.5B
Financing Cash Flow i-497.6M1.8B1.2B-415.6M-1.8B
Free Cash Flow i428.7M497.5M460.7M365.1M336.3M
Net Change in Cash i-93.0M340.2M-10.0M57.6M-1.4B

Cash Flow Trend

Concentrix Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 12.99
Forward P/E 3.85
Price to Book 0.70
Price to Sales 0.31
PEG Ratio -0.36

Profitability Ratios

Profit Margin 2.54%
Operating Margin 6.83%
Return on Equity 5.85%
Return on Assets 3.78%

Financial Health

Current Ratio 1.61
Debt to Equity 135.96
Beta 0.58

Per Share Data

EPS (TTM) $3.65
Book Value per Share $67.99
Revenue per Share $150.18

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
cnxc3.0B12.990.705.85%2.54%135.96
International 224.8B38.928.1722.67%9.11%245.47
Accenture plc 157.9B20.175.1726.93%11.61%25.88
Epam Systems 9.3B23.932.5411.35%7.91%4.44
Parsons 8.4B35.273.3412.44%3.70%56.60
Genpact 7.6B14.512.9421.86%10.92%59.21

Financial data is updated regularly. All figures are in the company's reporting currency.